Genetics: How to validate a breast cancer prognostic signature

Nature Reviews Clinical Oncology

Volumn 7, Issue 11, 2010, Pages 615-616

  Pharoah, Paul D ^a   Caldas, Carlos ^b  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR; MOLECULAR MARKER; PROTEIN BCL 2;

ACCURACY; BREAST CANCER; CANCER GRADING; CANCER PATIENT; CANCER SIZE; CANCER STAGING; CANCER SURVIVAL; GENE EXPRESSION; HUMAN; MEDICAL DECISION MAKING; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RISK ASSESSMENT; SHORT SURVEY; STATISTICAL MODEL; VALIDATION PROCESS;

BREAST NEOPLASMS; FEMALE; GENE EXPRESSION; GENETIC MARKERS; HUMANS; MOLECULAR BIOLOGY; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RISK ASSESSMENT; RISK FACTORS;

EID: 78049452104     PISSN: 17594774     EISSN: 17594782     Source Type: Journal    
DOI: 10.1038/nrclinonc.2010.142     Document Type: Short Survey

References (10)

1. Mook, S. et al. The 70-gene prognosis signature predicts early metastasis in breast cancer patients between 55 and 70 years of age. Ann. Oncol. 21, 717-722 (2010).
2. Van 't veer, L. J et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature. 415. 530-536 (2002).
3. Azzato, E. M. et al. Prevalent cases in observational studies of cancer survival: do they bias hazard ratio estimates? Br. J. Cancer 100, 1806-1811 (2009).
4. Blows, F. M. et al. Subtyping of breast cancer by immunohistochemistry to investigate a relationship between subtype and short and long term survival: a collaborative analysis of data for 10,159 cases from 12 studies. PLoS Med. 7, e1000279 (2010).
5. Blamey, R. W. et al. survival of invasive breast cancer according to the nottingham Prognostic index in cases diagnosed in 1990-1999. Eur. J. Cancer 43, 1548-1555 (2007).
6. Ravdin, P M. et al. Computer program to assist in making decisions about adjuvant therapy for women with early breast cancer. J. Clin. Oncol. 19, 980-991 (2001).
7. Wishart, G. C. et al. PReDiCT: a new UK prognostic model that predicts survival following surgery for invasive breast cancer. Breast Cancer Res. 12, R1 (2010).
8. Dawson, S. J. et al. BCL2 in breast cancer: a favourable prognostic marker across molecular subtypes and independent of adjuvant therapy received. Br. J. Cancer 103, 668-675 (2010).
9. Teschendorff, A. E. et al. A consensus prognostic gene expression classifier for eR positive breast cancer. Genome Biol. 7, R101 (2006).
10. Cardoso, F. et al. Clinical application of the 70-gene profile: the MinDACT trial. J. Clin. Oncol. 26, 729-735 (2008).